InjectSense Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Series C
  • (In Progress)

  • Investors
  • 4

InjectSense General Information

Description

Developer of an injectable wireless pressure sensor designed to improve therapy procedures. The company's sensors monitor patient profiles for glaucoma and also focus on minimally invasive assistance to generate clinically actionable information for therapy management and outcome, enabling medical professionals to treat glaucoma diseases in an effective, efficient, convenient, and hassle-free manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Biotechnology
Primary Office
  • 2000 Powell Street
  • Suite 1425
  • Emeryville, CA 94608
  • United States
+1 (510) 000-0000

InjectSense Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InjectSense Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series C) 00.00 In Progress Product Development
7. Later Stage VC 23-Nov-2023 00.00 00.00 Completed Product Development
6. Grant 17-Mar-2022 00.00 00.00 Completed Product Development
5. Grant 01-Feb-2022 00000 00.00 Completed Product Development
4. Debt - PPP 30-Apr-2020 00.00 Completed Startup
3. Later Stage VC (Series B) 23-Apr-2019 00.000 00.00 000.00 Completed Startup
2. Early Stage VC (Series A) 10-Oct-2017 $9.8M $9.8M 000.00 Completed Startup
1. Seed Round 01-Jan-2016 Completed Startup
To view InjectSense’s complete valuation and funding history, request access »

InjectSense Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A2 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A1 1,434,373 $0.001000 8% $1.28 $1.28 1x $1.28 10.89%
To view InjectSense’s complete cap table history, request access »

InjectSense Patents

InjectSense Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220280038-A1 Circadian intraocular pressure profile and methods of treatment Pending 08-Mar-2021 00000000
US-20220117488-A1 Hermetic heterogeneous integration platform for active and passive electronic components Pending 03-Jul-2019 00000000
EP-4242614-A3 Hermetically sealed implant sensors with vertical stacking architecture Pending 01-Jul-2015
US-20160058324-A1 Ultra low power charging implant sensors with wireless interface for patient monitoring Inactive 02-Sep-2014 000000000 00
EP-3164061-A4 Methods and devices for implantation of intraocular pressure sensors Pending 01-Jul-2014 A61B3/16 0
To view InjectSense’s complete patent history, request access »

InjectSense Executive Team (3)

Name Title Board Seat Contact Info
Ariel Cao Co-Founder, Chief Executive Officer, President & Board Member
Enrique Malaret Co-Founder, Lead of Medical Systems Chief Operating Officer & Board Member
Cenk Acar Co-Founder & Vice President of Mems
To view InjectSense’s complete executive team members history, request access »

InjectSense Board Members (2)

Name Representing Role Since
Enrique Malaret InjectSense Co-Founder, Lead of Medical Systems Chief Operating Officer & Board Member 000 0000
You’re viewing 1 of 2 board members. Get the full list »

InjectSense Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InjectSense Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Doliam Corporation Minority 000 0000 000000 0
National Eye Institute Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
Microtech Ventures Venture Capital Minority 000 0000 000000 0
To view InjectSense’s complete investors history, request access »